10.7 C
Madrid
Friday, November 27, 2020

Pfizer To Start COVID-19 Vaccine Delivery Program In Four US States

Pfizer and its partner company BioNTech have a $1.95 billion deal to supply 100 million doses of the vaccine to the U.S. government.

Must read

Ishita Chakraborty
Ishita Chakraborty
A computer engineer who has a passion for writing, a hodophile, social activist, youth activist for PETA India, and a linguaphile. A journalist covering Social issues & United Nations initiatives for transcontinental times.

UNITED STATES: Pfizer Inc., an American multinational pharmaceutical corporation has recently launched a pilot delivery program for its COVID-19 vaccine in four U.S. states ; Rhode Island, Texas, New Mexico, and Tennessee were selected for the vaccine distribution program.

The overall size, diversity of populations, and immunization infrastructure were taken into account during the selection process.

Challenges of the COVID-19 vaccine

- Advertisement -

The U.S. drugmaker is aiming to address distribution challenges. Interestingly, the COVID-19 vaccine requires to be stored in ultra-cold conditions.

The vaccine must be shipped and stored at -70 degrees Celsius (minus 94°F). Due to this, the pharmaceutical incorporation is facing distribution challenges.

- Advertisement -

In a statement, Pfizer said, “We are hopeful that results from this vaccine delivery pilot will serve as the model for other U.S. states and international governments, as they prepare to implement effective COVID-19 vaccine programs.”

The company is expecting to have enough safety data on the vaccine from the ongoing large scale trials by the third week of November.

- Advertisement -

After that, the company will proceed to apply for emergency use authorization (EUA).

Pfizer and its partner company BioNTech have a $1.95 billion deal to supply 100 million doses of the vaccine to the U.S. government.

Meanwhile, the government has an option to acquire up to an additional 500 million vaccine doses.

On Monday, Pfizer’s rival company Moderna Inc. claimed that its experimental vaccines were 94.5% effective in preventing COVID-19.

Pfizer and Moderna vaccines use a new technology called ‘synthetic messenger RNA’ to activate the immune system against the COVID-19 virus.

More articles

Latest article

Boxing Legend Mike Tyson To Make A Comeback After 15 Years

UNITED STATES. Los Angeles: Former heavyweight world champion Mike Tyson, popularly known as ‘Iron Mike’ will be back in the ring after...

An Ode To The Greatest Footballer Of The Century

ARGENTINA: Soccer legend Diego Maradona passed away after suffering a heart attack on Wednesday. Maradona died at his home situated in the...

Americans Face Difficult Thanksgiving Decisions Amid COVID-19 Surge

UNITED STATES: Thanksgiving is the kick-off to the holiday season in the United States. A turkey can be found cooking in the...

New Stylebook Promotes Slow Fashion

PHILIPPINES. Quezon City: KC Leyco Mempin, or Miss Kayce, has been a wardrobe and personal stylist for 15 years. She has written a...

Recent Arrest And Treatment Of Jailed Reporter Raises Questions About The Safety Of Journalists In India

INDIA: Journalist Prashant Kanojia was arrested by the Uttar Pradesh (UP) police on 18 August. Kanojia was arrested for sharing a widely...